Grantham, Mayo, Van Otterloo & Co (GMO)
ESRX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Express Scripts Holding Company ESRX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-217,000
Closed -$16.8M – 623
2018
Q2 		$16.8M Buy
+217,000
New +$16.3M 0.12% 114

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ESRX Position: Q4 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 308,600 shares — an estimated $29.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ESRX in Q2 2013 and held it in 18 quarters. The position peaked at $2.05B in Q4 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 308,600 Express Scripts Holding Company shares in Q4 2018, an estimated $29.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 18 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Express Scripts Holding Company position peaked at $2.05B in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2018, filed 13 Feb 2019.